= Full article availableAbstract
In the 12 months following researchers’ decision to put an early end to a trial on menopause-related hormone therapy because of data showing a significant increase in the risk for heart disease and breast cancer among those who took it, prescriptions for the therapy dropped by two-thirds. The thing is, the number of women who experience the hot flashes for which hormone therapy was developed has not dropped and, in fact, is likely to rise as more and more baby boomer women enter perimenopause and menopause. What’s a woman to do?
The full text of this article is not available online. Order this issue »